Nucleolar organizer regions (AgNOR) and Ki-67 immunoreactivity in cutaneous melanocytic lesions

F. Fogt, Alexander Vortmeyer, S. R. Tahan

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

A stepwise schema for the developmental biology of malignant melanomas has been proposed. In this study, two properties associated with malignant transformation-AgNOR production and Ki-67 immunoreactivity-were tested on a series of lesions representative of this model. Fourteen ordinary nevi (N), seven dysplastic nevi (DN), 12 radial growth phase melanomas (RGPM), and eight vertical growth phase melanomas (VGPM) were stained for AgNORs; Ki-67 immunoreactivity was determined in paraffin sections after antigen retrieval. AgNORs averaged 2.1 in N, 3.8 in DN, 5.4 in RGPM, and 7.3 in VGPM (p < 0.001 between all groups). Ki-67 immunoreactivity averaged <1 in nevi, 1.6 in dysplastic nevi, 23.3 in RGPM, and 20.1 in VGPM. No difference was observed between N and DN, and RGPM/VGPM had higher Ki-67 indices than N/DN (p < 0.01). Stepwise increases in cellular AgNORs parallel the melanocytic progression model and thereby corroborate the intermediate nature of the dysplastic nevus. The order of magnitude increase in Ki-67 immunoreactivity observed in RGP and VGP melanomas compared with N and DN likely reflects the onset of loss of cell cycle control in these lesions.

Original languageEnglish (US)
Pages (from-to)12-17
Number of pages6
JournalAmerican Journal of Dermatopathology
Volume17
Issue number1
StatePublished - Jan 31 1995
Externally publishedYes

Fingerprint

Nucleolus Organizer Region
Dysplastic Nevus Syndrome
Melanoma
Skin
Growth
Nevus
nucleolar organizer region associated proteins
Developmental Biology
Cell Cycle Checkpoints
Paraffin

Keywords

  • AgNOR
  • Dysplastic nevus
  • Ki-67
  • Melanocytic lesions
  • Melanoma
  • MIB-1
  • Nucleolar organizer region

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Dermatology

Cite this

Nucleolar organizer regions (AgNOR) and Ki-67 immunoreactivity in cutaneous melanocytic lesions. / Fogt, F.; Vortmeyer, Alexander; Tahan, S. R.

In: American Journal of Dermatopathology, Vol. 17, No. 1, 31.01.1995, p. 12-17.

Research output: Contribution to journalArticle

@article{0cbd53bb6c4348638e98c2e961f4e972,
title = "Nucleolar organizer regions (AgNOR) and Ki-67 immunoreactivity in cutaneous melanocytic lesions",
abstract = "A stepwise schema for the developmental biology of malignant melanomas has been proposed. In this study, two properties associated with malignant transformation-AgNOR production and Ki-67 immunoreactivity-were tested on a series of lesions representative of this model. Fourteen ordinary nevi (N), seven dysplastic nevi (DN), 12 radial growth phase melanomas (RGPM), and eight vertical growth phase melanomas (VGPM) were stained for AgNORs; Ki-67 immunoreactivity was determined in paraffin sections after antigen retrieval. AgNORs averaged 2.1 in N, 3.8 in DN, 5.4 in RGPM, and 7.3 in VGPM (p < 0.001 between all groups). Ki-67 immunoreactivity averaged <1 in nevi, 1.6 in dysplastic nevi, 23.3 in RGPM, and 20.1 in VGPM. No difference was observed between N and DN, and RGPM/VGPM had higher Ki-67 indices than N/DN (p < 0.01). Stepwise increases in cellular AgNORs parallel the melanocytic progression model and thereby corroborate the intermediate nature of the dysplastic nevus. The order of magnitude increase in Ki-67 immunoreactivity observed in RGP and VGP melanomas compared with N and DN likely reflects the onset of loss of cell cycle control in these lesions.",
keywords = "AgNOR, Dysplastic nevus, Ki-67, Melanocytic lesions, Melanoma, MIB-1, Nucleolar organizer region",
author = "F. Fogt and Alexander Vortmeyer and Tahan, {S. R.}",
year = "1995",
month = "1",
day = "31",
language = "English (US)",
volume = "17",
pages = "12--17",
journal = "American Journal of Dermatopathology",
issn = "0193-1091",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Nucleolar organizer regions (AgNOR) and Ki-67 immunoreactivity in cutaneous melanocytic lesions

AU - Fogt, F.

AU - Vortmeyer, Alexander

AU - Tahan, S. R.

PY - 1995/1/31

Y1 - 1995/1/31

N2 - A stepwise schema for the developmental biology of malignant melanomas has been proposed. In this study, two properties associated with malignant transformation-AgNOR production and Ki-67 immunoreactivity-were tested on a series of lesions representative of this model. Fourteen ordinary nevi (N), seven dysplastic nevi (DN), 12 radial growth phase melanomas (RGPM), and eight vertical growth phase melanomas (VGPM) were stained for AgNORs; Ki-67 immunoreactivity was determined in paraffin sections after antigen retrieval. AgNORs averaged 2.1 in N, 3.8 in DN, 5.4 in RGPM, and 7.3 in VGPM (p < 0.001 between all groups). Ki-67 immunoreactivity averaged <1 in nevi, 1.6 in dysplastic nevi, 23.3 in RGPM, and 20.1 in VGPM. No difference was observed between N and DN, and RGPM/VGPM had higher Ki-67 indices than N/DN (p < 0.01). Stepwise increases in cellular AgNORs parallel the melanocytic progression model and thereby corroborate the intermediate nature of the dysplastic nevus. The order of magnitude increase in Ki-67 immunoreactivity observed in RGP and VGP melanomas compared with N and DN likely reflects the onset of loss of cell cycle control in these lesions.

AB - A stepwise schema for the developmental biology of malignant melanomas has been proposed. In this study, two properties associated with malignant transformation-AgNOR production and Ki-67 immunoreactivity-were tested on a series of lesions representative of this model. Fourteen ordinary nevi (N), seven dysplastic nevi (DN), 12 radial growth phase melanomas (RGPM), and eight vertical growth phase melanomas (VGPM) were stained for AgNORs; Ki-67 immunoreactivity was determined in paraffin sections after antigen retrieval. AgNORs averaged 2.1 in N, 3.8 in DN, 5.4 in RGPM, and 7.3 in VGPM (p < 0.001 between all groups). Ki-67 immunoreactivity averaged <1 in nevi, 1.6 in dysplastic nevi, 23.3 in RGPM, and 20.1 in VGPM. No difference was observed between N and DN, and RGPM/VGPM had higher Ki-67 indices than N/DN (p < 0.01). Stepwise increases in cellular AgNORs parallel the melanocytic progression model and thereby corroborate the intermediate nature of the dysplastic nevus. The order of magnitude increase in Ki-67 immunoreactivity observed in RGP and VGP melanomas compared with N and DN likely reflects the onset of loss of cell cycle control in these lesions.

KW - AgNOR

KW - Dysplastic nevus

KW - Ki-67

KW - Melanocytic lesions

KW - Melanoma

KW - MIB-1

KW - Nucleolar organizer region

UR - http://www.scopus.com/inward/record.url?scp=0028853418&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028853418&partnerID=8YFLogxK

M3 - Article

C2 - 7695006

AN - SCOPUS:0028853418

VL - 17

SP - 12

EP - 17

JO - American Journal of Dermatopathology

JF - American Journal of Dermatopathology

SN - 0193-1091

IS - 1

ER -